NET Specialists Update
A warm welcome to Robert Ramirez, DO (pictured left below) and Hagen Kennecke, MD (pictured right below) on their new appointments in Tennessee and Oregon, respectively.
Dr. Robert Ramirez, a thoracic and neuroendocrine oncologist, has joined …
READ MORE
NANETS Offers Free, Virtual NET Patient Education Programs in May and June
The North American Neuroendocrine Tumor Society, NANETS, is offering free, virtual NET Patient Programs in conjunction with their regional medical education conferences. Neuroendocrine tumor patients can participate in interactive programs …
READ MORE
Ferrari Maserati Long Island’s Annual Rally to Red Tomato Artisanal Pizza to Honor Eileen “Red” Bildman and Support the Carcinoid Cancer Foundation
When Eileen “Red” Bildman was diagnosed with neuroendocrine cancer in 2017 little did she know how her life was going to change. It took her well over 10 years and numerous visits to many different specialty physicians, including gastroenterologists,…
READ MORE
Dr. Boris Naraev to be Featured Guest for Luncheon with the Experts
Boris Naraev, MD, PhD, FACP, medical oncologist, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, April 22 from 12 noon to 1 pm, Eastern Time. Dr. Naraev leads the Neuroendocrine Oncology Program at Banner…
READ MORE
Dr. Lale Kostakoglu-Shields to Be Featured Guest for Luncheon with the Experts
Lale Kostakoglu-Shields, MD, MPH, a nuclear medicine expert, will be the featured guest for CCF’s Luncheon with the Experts on Thursday, April 15, 2021 from 12 noon to 1 pm, Eastern Time. Dr. Kostakoglu-Shields is a professor of radiology and medical…
READ MORE
Dr. Ebrahim Delpassand to be Featured Guest for CCF’s Luncheon with the Experts
Ebrahim S. Delpassand, MD, FACNM, Chairman and Medical Director at Excel Diagnostics & Nuclear Oncology Center in Houston, Texas and founder, Chairman of the Board, and CEO of Radiomedix in Houston, will be the featured guest for Luncheon with the…
READ MORE
CCF Releases New Video on Surgery for Neuroendocrine Tumors
Many doctors have historically considered surgery the first and best option for treating a neuroendocrine tumor (NET), when appropriate for their patients. But with all the treatments that have emerged over the past 10 years, as well as new perspectives…
READ MORE
NANETS Issues Position Statement on COVID-19 Vaccination for NET and NEC Patients
A growing body of evidence suggests that patients with cancer have an increased risk of severe COVID-19 infection and related complications. As such, NANETS, the North American Neuroendocrine Tumor Society, supports the plan for COVID-19 vaccination…
READ MORE
2020 Monica Warner Award: Call for Nominations
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work of…
READ MORE
Understanding Patient Preferences in Neuroendocrine Tumor Treatments
When you meet with your healthcare team do you discuss what is important to you as you consider neuroendocrine tumor treatment options? You can help physicians better understand patient-centered treatment decision making by participating in this…
READ MORE
